132MO Anti-claudin18.2 (CLDN18.2) Antibody-Drug Conjugate (ADC) IBI343 in Patients (pts) with Advanced Pancreatic Ductal Adenocarcinoma (PDAC): Updated Results from a Phase I Study

X. Yu, J. Zhang, J.J. Liu, J. Yang,J. Yue, Y. Sun, Y. Pan, M.L. Sun, Y. Qin, L. Shen, R. Song, J. Ruan, A. Zhou, Y. Mou,M. Aghmesheh, M. Morris, X. Zhao, M. Chen, A. Tazbirkova

Annals of Oncology（2024）

引用 0|浏览0